Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer

BACKGROUND: Approximately 10–20% of patients diagnosed with prostate cancer (PCa) evolve into castration-resistant prostate cancer (CRPC), while nearly 90% of patients with metastatic CRPC (mCRPC) exhibit osseous metastases (BM). These BM are intimately correlated with the stability of the tumour mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qingfu, Zhang, Peng, Zhao, Zhongting, Wang, Jun, Zhang, Hepeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105558/
https://www.ncbi.nlm.nih.gov/pubmed/37070095
http://dx.doi.org/10.7717/peerj.15013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105558/
https://www.ncbi.nlm.nih.gov/pubmed/37070095
http://dx.doi.org/10.7717/peerj.15013

Ejemplares similares